These targets may enhance bone cell proliferation through various potential influencing pathways, including the PI3K-Akt signaling pathway, lipid metabolism and atherosclerosis, EGFR TKI resistance, and the MAPK signaling pathway. The gene discussed is EGFR; the disease is atherosclerosis.